A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives
Acta Pharmaceutica Sinica B
;
(6): 2396-2415, 2021.
Article
in English
| WPRIM
| ID: wpr-888867
ABSTRACT
The need for long-term treatments of chronic diseases has motivated the widespread development of long-acting parenteral formulations (LAPFs) with the aim of improving drug pharmacokinetics and therapeutic efficacy. LAPFs have been proven to extend the half-life of therapeutics, as well as to improve patient adherence; consequently, this enhances the outcome of therapy positively. Over past decades, considerable progress has been made in designing effective LAPFs in both preclinical and clinical settings. Here we review the latest advances of LAPFs in preclinical and clinical stages, focusing on the strategies and underlying mechanisms for achieving long acting. Existing strategies are classified into manipulation of
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Acta Pharmaceutica Sinica B
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS